I share your sentiment Pohutukawa because what was communicated which seemed to be a cure and a quick treatment. What they didnt say earlier was the radiotherapy dose is palliative and it needs 24 weeks to fully see the results. That being said, the news is encouraging as reading on thw graph, the 1200 have a good PSA response so hard to tell if it is helping with the other tumours. You cant attrribute the psa response to a palliative radiotherapy dosage. I am a bit curious if 1200 is the ideal dosage, why Lupin trial is using 800. It must have worked for them not to try 1200.
- Forums
- ASX - By Stock
- NOX
- Ann: Veyonda and Radiotherapy Delivers Clinical Benefits
Ann: Veyonda and Radiotherapy Delivers Clinical Benefits, page-7
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
-0.005(5.75%) |
Mkt cap ! $23.96M |
Open | High | Low | Value | Volume |
8.7¢ | 8.7¢ | 8.1¢ | $50.65K | 608.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 131400 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 7168 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 131400 | 0.082 |
2 | 170000 | 0.081 |
2 | 200000 | 0.080 |
1 | 15000 | 0.078 |
1 | 14091 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 7168 | 1 |
0.091 | 10989 | 1 |
0.093 | 37410 | 1 |
0.095 | 54200 | 2 |
0.096 | 35000 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |